Journal Club

2019

An environmental cleaning bundle and health-care-associated infections in hospitals (REACH): a multicentre, randomised tria
09.04.2019 (Matthias von Rotz)
Mitchell BG. et al. An environmental cleaning bundle and health-care-associated infections in hospitals (REACH): a multicentre, randomised trial Lancet Infect Dis 19: 410-18 2019
Use of ribaxamase (SYN-004), a β-lactamase, to prevent Clostridium difficile infection in β-lactam-treated patients: a double-blind, phase 2b, randomised placebo-controlled trial
01.04.2019 (Sabine Kuster)
Kokai-Kun J. et al.: Use of ribaxamase (SYN-004), a β-lactamase, to prevent Clostridium difficile infection in β-lactam-treated patients: a double-blind, phase 2b, randomised placebo-controlled trial
Lancet Infect Dis Published Online March 15, 2019
HIV-1 remission following CCR5Δ32/Δ32 haematopoietic stem-cell transplantation


25.03.2019 (Sarah Dräger)
Ravindra K Gupta: HIV-1 remission following CCR5Δ32/Δ32 haematopoietic stem-cell transplantation Nature 2019

Colonization With Levofloxacin-resistant Extended-spectrum β-Lactamase-producing Enterobacteriaceae and Risk of Bacteremia in Hematopoietic Stem Cell Transplant Recipients
04.03.2019 (Veronika Bättig)
Satlin MJ et al.: Colonization With Levofloxacin-resistant Extended-spectrum β-Lactamase-producing Enterobacteriaceae and Risk of Bacteremia in Hematopoietic Stem Cell Transplant Recipients Clin Infect Dis. 67 1720-1728 2018
Acute Exacerbations of Chronic Obstructive Pulmonary Disease With a Low Procalcitonin Concentration: Impact of Antibiotic Therapy
25.02.2019 (Elisabeth Wehrle)
Bremmer D.N. et. Al.: Acute Exacerbations of Chronic Obstructive Pulmonary Disease With a Low Procalcitonin Concentration: Impact of Antibiotic Therapy CID 68 725-30 2019
Seven versus fourteen Days of Antibiotic Therapy for uncomplicated Gram-negative Bacteremia: a Non-inferiority Randomized Controlled Trial
18.02.2019 (Jacopo Nicoletti)
Yahav D. et al.: Seven versus fourteen Days of Antibiotic Therapy for uncomplicated Gram-negative Bacteremia: a Non-inferiority Randomized Controlled Trial Clin. Infect. Dis. ePub 11.12.2018
Frequency, symptoms, risk factors, and outcomes of autoimmune encephalitis after herpes simplex encephalitis: a prospective observational study and retrospective analysis


11.02.2019 (Kai-Manuel Adam)
Armangue T. et al.: Frequency, symptoms, risk factors, and outcomes of autoimmune encephalitis after herpes simplex encephalitis: a prospective observational study and retrospective analysis Lancet Neurol 17 760–72 2018

Efficacy of Ceftazidime-Avibactam Salvage Therapy in Patients With Infections Caused by Klebsiella pneumonia Carbapenemase-producing K. pneumoniae
28.01.2019 (Sabine Kuster)
Tumbarello M. et al: Efficacy of Ceftazidime-Avibactam Salvage Therapy in Patients With Infections Caused by Klebsiella pneumonia Carbapenemase-producing K. pneumoniae CID Volume 68-3 355-64 2019
A prospective study of transmission of Multidrug-Resistant Organisms (MDROs) between environmental sites and hospitalized patients – the TransFER study
21.01.2019 (Andrea Büchler)
Chen F. et al: A prospective study of transmission of Multidrug-Resistant Organisms (MDROs) between environmental sites and hospitalized patients – the TransFER study ICHE 40 47-52 2019
Substitution of ethambutol with linezolid during the intensive phase of treatment of pulmonary tuberculosis: a prospective, multicentre, randomised, open-label, phase 2 trial
14.01.2019 (Niklaus Labhardt)
Jung-Kyu Lee et al.: Substitution of ethambutol with linezolid during the intensive phase of treatment of pulmonary tuberculosis: a prospective, multicentre, randomised, open-label, phase 2 trial
Lancet Infect Dis 19 46-55 2019

Efficacy, effectiveness, and safety of herpes zoster vaccines in adults aged 50 and older: systematic review and network meta-analysis

07.01.2019 (Matthias von Rotz)
Tricco AC et al. : Efficacy, effectiveness, and safety of herpes zoster vaccines in adults aged 50 and older: systematic review and network meta-analysis BMJ 363:k4029 2018